Literature DB >> 26482751

Management of Hypertension in Obstructive Sleep Apnea.

Sofia F Furlan1, Caio V Braz2, Geraldo Lorenzi-Filho3, Luciano F Drager4,5.   

Abstract

Obstructive sleep apnea (OSA) is considered to be a secondary form of hypertension and in clinical practice OSA is frequently associated with hypertension, even if proof of causality cannot be established. Growing evidence suggests that OSA is associated with worse blood pressure control, alterations in night-time blood pressure dipping, increased target organ damage, and arterial stiffness in patients with hypertension. This review summarizes the current evidence for managing hypertension in patients with OSA. Particular focus will be devoted to discuss the impact of lifestyle changes, preferences for anti-hypertensive treatment in patients with OSA, and the effects of OSA treatment with continuous positive airway pressure on blood pressure.

Entities:  

Keywords:  CPAP; Cardiovascular disease; Hypertension; Sleep apnea; Treatment

Mesh:

Substances:

Year:  2015        PMID: 26482751     DOI: 10.1007/s11886-015-0663-z

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  56 in total

Review 1.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

Authors: 
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

2.  Evening versus morning dosing of antihypertensive drugs in hypertensive patients with sleep apnoea: a cross-over study.

Authors:  Alexandros Kasiakogias; Costas Tsioufis; Costas Thomopoulos; Ioannis Andrikou; Dimitrios Aragiannis; Kyriakos Dimitriadis; Dimitrios Tsiachris; Grzegorz Bilo; Skevos Sideris; Konstantinos Filis; Gianfranco Parati; Christodoulos Stefanadis
Journal:  J Hypertens       Date:  2015-02       Impact factor: 4.844

3.  High prevalence of unrecognized sleep apnoea in drug-resistant hypertension.

Authors:  A G Logan; S M Perlikowski; A Mente; A Tisler; R Tkacova; M Niroumand; R S Leung; T D Bradley
Journal:  J Hypertens       Date:  2001-12       Impact factor: 4.844

4.  Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension.

Authors:  Rodrigo P Pedrosa; Luciano F Drager; Carolina C Gonzaga; Marcio G Sousa; Lílian K G de Paula; Aline C S Amaro; Celso Amodeo; Luiz A Bortolotto; Eduardo M Krieger; T Douglas Bradley; Geraldo Lorenzi-Filho
Journal:  Hypertension       Date:  2011-10-03       Impact factor: 10.190

5.  Association between blood pressure reduction with antihypertensive treatment and sleep apnea activity.

Authors:  L Grote; K Wutkewicz; L Knaack; T Ploch; J Hedner; J H Peter
Journal:  Am J Hypertens       Date:  2000-12       Impact factor: 2.689

6.  Impact of OSA on cardiovascular events after coronary artery bypass surgery.

Authors:  Carlos Henrique G Uchôa; Naury de Jesus Danzi-Soares; Flávia S Nunes; Altay A L de Souza; Flávia B Nerbass; Rodrigo P Pedrosa; Luiz Antonio M César; Geraldo Lorenzi-Filho; Luciano F Drager
Journal:  Chest       Date:  2015-05       Impact factor: 9.410

7.  Nasal continuous positive airway pressure improves myocardial perfusion reserve and endothelial-dependent vasodilation in patients with obstructive sleep apnea.

Authors:  Patricia K Nguyen; Chandra K Katikireddy; Michael V McConnell; Clete Kushida; Phillip C Yang
Journal:  J Cardiovasc Magn Reson       Date:  2010-09-03       Impact factor: 5.364

8.  Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial.

Authors:  Rodrigo P Pedrosa; Luciano F Drager; Lílian K G de Paula; Aline C S Amaro; Luiz A Bortolotto; Geraldo Lorenzi-Filho
Journal:  Chest       Date:  2013-11       Impact factor: 9.410

Review 9.  Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome.

Authors:  Luciano F Drager; Sônia M Togeiro; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho
Journal:  J Am Coll Cardiol       Date:  2013-06-12       Impact factor: 24.094

10.  A randomized, double crossover study to investigate the influence of saline infusion on sleep apnea severity in men.

Authors:  Azadeh Yadollahi; Joseph M Gabriel; Laura H White; Luigi Taranto Montemurro; Takatoshi Kasai; T Douglas Bradley
Journal:  Sleep       Date:  2014-10-01       Impact factor: 5.849

View more
  7 in total

Review 1.  Sleep disturbances: one of the culprits of obesity-related cardiovascular risk?

Authors:  Giovanna Muscogiuri; Dario Tuccinardi; Vincenzo Nicastro; Luigi Barrea; Annamaria Colao; Silvia Savastano
Journal:  Int J Obes Suppl       Date:  2020-07-20

2.  Morning Diastolic Blood Pressure May Be Independently Associated With Severity of Obstructive Sleep Apnea in Non-Hypertensive Patients: A Cross-Sectional Study.

Authors:  Łukasz Mokros; Wojciech Kuczyński; Łukasz Franczak; Piotr Białasiewicz
Journal:  J Clin Sleep Med       Date:  2017-07-15       Impact factor: 4.062

3.  Bariatric surgery short-term outcomes in patients with obstructive sleep apnoea: the Severe Obesity Outcome Network prospective cohort.

Authors:  Jessica Guggino; Renaud Tamisier; Cécile Betry; Sandrine Coumes; Catherine Arvieux; Nelly Wion; Fabian Reche; Jean-Louis Pépin; Anne-Laure Borel
Journal:  Int J Obes (Lond)       Date:  2021-08-27       Impact factor: 5.095

Review 4.  Effectiveness of continuous positive airway pressure in lowering blood pressure in patients with obstructive sleep apnea: a critical review of the literature.

Authors:  Fernanda Fatureto-Borges; Geraldo Lorenzi-Filho; Luciano F Drager
Journal:  Integr Blood Press Control       Date:  2016-03-15

5.  7th Brazilian Guideline of Arterial Hypertension: Chapter 12 - Secondary Arterial Hypertension

Authors:  M V B Malachias; L A Bortolotto; L F Drager; F A O Borelli; L A D Lotaif; L C Martins
Journal:  Arq Bras Cardiol       Date:  2016-09       Impact factor: 2.000

Review 6.  Sleep Apnea and Sleep Habits: Relationships with Metabolic Syndrome.

Authors:  Anne-Laure Borel
Journal:  Nutrients       Date:  2019-11-02       Impact factor: 5.717

7.  Obstructive sleep apnea, hypertension, resistant hypertension and cardiovascular disease.

Authors:  Shazia Jehan; Ferdinand Zizi; Seithikurippu R Pandi-Perumal; Samy I McFarlane; Girardin Jean-Louis; Alyson K Myers
Journal:  Sleep Med Disord       Date:  2020-11-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.